Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

6(100.0%)

6Total

N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06519487Not ApplicableEnrolling By Invitation

Social Experiences and Demographic Factors in the Regulation of Immune Cells

Role: lead

NCT06347484Not ApplicableActive Not Recruiting

Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)

Role: collaborator

NCT05754658Recruiting

African Cancer Genome: GMD

Role: collaborator

NCT06633367Not ApplicableCompleted

Nature IDEAS Study: An RCT to Increase Time Spent in Nature Among University Students

Role: collaborator

NCT06522685Not ApplicableNot Yet Recruiting

Neural and Immune Correlates of CIPN and Possible Analgesic Effect of Non-invasive Motor Cortex Stimulation

Role: lead

NCT06053762Not ApplicableRecruiting

Identify the Usefulness of Peer-facilitated Versus Self-navigated Quit Tobacco Program for Youths.

Role: lead

NCT05181072Not ApplicableCompleted

Identify the Usefulness of In-person and Virtual Quit Smoking Programs

Role: lead

All 7 trials loaded